Luther King Capital Management (LKCM)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,603
Closed -$307K 530
2015
Q4
$307K Hold
2,603
﹤0.01% 457
2015
Q3
$229K Buy
2,603
+3
+0.1% +$349 ﹤0.01% 490
2015
Q2
$282K Hold
2,600
﹤0.01% 491
2015
Q1
$328K Hold
2,600
﹤0.01% 474
2014
Q4
$330K Hold
2,600
﹤0.01% 482
2014
Q3
$349K Buy
2,600
+230
+10% +$32.2K ﹤0.01% 485
2014
Q2
$385K Buy
+2,370
New +$403K ﹤0.01% 474

Other funds holding TNDM

Luther King Capital Management (LKCM)'s TNDM Position: Q1 2016 in Review

Luther King Capital Management (LKCM) sold out of Tandem Diabetes Care (TNDM) in Q1 2016, closing a stake of 2,603 shares — an estimated $307K sold.

Luther King Capital Management (LKCM) first reported a position in TNDM in Q2 2014 and held it in 7 quarters. The position peaked at $385K in Q2 2014. 91 funds tracked by Wall St. Rank hold TNDM as of Q1 2016.

  • Luther King Capital Management (LKCM) reported no remaining Tandem Diabetes Care position as of Q1 2016 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 2,603 Tandem Diabetes Care shares in Q1 2016, an estimated $307K.
  • Luther King Capital Management (LKCM) first reported a position in Tandem Diabetes Care in Q2 2014 and held it in 7 quarters.
  • Luther King Capital Management (LKCM)'s Tandem Diabetes Care position peaked at $385K in Q2 2014.
  • 91 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2016.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2016, filed 12 May 2016.